Related Experiment Videos
Corticosteroid treatment, serum lipids and coronary artery disease
Insights
Long-term corticosteroid use, like prednisolone, significantly alters cholesterol levels in women. This study found decreased high-density lipoprotein (HDL) cholesterol in female patients, potentially increasing heart disease risk.
Area of Science:
- Cardiovascular Medicine
- Endocrinology
- Rheumatology
Background:
- Corticosteroids are widely used for treating connective tissue disorders and asthma.
- The impact of long-term corticosteroid therapy on lipid profiles requires further investigation, particularly concerning cardiovascular risk.
Purpose of the Study:
- To assess the effects of long-term corticosteroid treatment on serum lipid profiles.
- To investigate potential differences in lipid changes between genders.
Main Methods:
- Serum lipid levels and high-density lipoprotein (HDL) cholesterol concentrations were measured.
- Patients receiving long-term corticosteroid treatment were compared to a control group.
- Data were analyzed for gender-specific effects.
Main Results:
- Patients on long-term corticosteroids showed no significant difference in lipid levels compared to healthy individuals.
- Female patients on prednisolone for an average of 3.1 years exhibited significantly elevated total cholesterol.
- A marked decrease in HDL cholesterol was observed in these female patients, but not in males.
Conclusions:
- Long-term corticosteroid treatment, specifically prednisolone, significantly impacts lipid metabolism in women.
- The observed decrease in HDL cholesterol in females may elevate the risk of premenopausal ischemic heart disease.
- Gender-specific monitoring of lipid profiles is crucial for patients on long-term corticosteroid therapy.
Abstract:
Serum lipids and the cholesterol concentrations in the high density lipoprotein (HDL) fractions were measured in patients receiving long-term corticosteroid treatment for connective tissue disorders and asthma. Patients who were not receiving corticosteroid treatment had blood lipid levels which did not differ from those of healthy people. However, female (but not male) patients who had received prednisolone for a mean period of 3.1 years had a significant elevation in total cholesterol and a large decrease in HDL cholesterol. It seems possible that high levels of corticosteroids may increase the incidence of premenopausal ischaemic heart disease in females.